We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Medicover Ab | LSE:0RPS | London | Ordinary Share | SE0009778848 | MEDICOVER ORD SHS CLASS B |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 81.20 | 79.20 | 83.20 | 5,920 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medical Laboratories | 1.75B | 17.6M | 0.2412 | 336.65 | 5.93B |
From Jun 2021 to Jun 2024
STOCKHOLM, Aug. 16, 2021 /PRNewswire/ -- Medicover has acquired the Norwegian Fertility company Klinikk Hausken and acquired 70 per cent of the voting rights for 18.2 MEUR including assumed debt. Revenue for 2020 amounted to 6.5 MEUR.
Klinikk Hausken is Norway's leading private IVF group and consist of four clinics performing over 2,800 cycles per annum, with the Oslo facility being Norway's largest private in-vitro clinic.
"Klinikk Hausken is a very well managed company and a good fit to our fertility network and given the liberalisation of the Norwegian IVF legalisation the market is expected to grow significantly ahead. The acquisition is a good foundation for further expansion in Norway," says James Barr, Managing Director of Fertility Services, Medicover.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
Tel.:+46 703 033 272
Email: hanna.bjellquist@medicover.com
The information was provided for publication by the abovementioned contact person at 15.00 CEST on 16 August 2021.
About Medicover:
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities,laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2020, Medicover had revenue of EUR 998 million and more than 32,000 employees. For more information, go to www.medicover.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/medicover/r/medicover-is-expanding-its-fertility-network-into-norway,c3396876
The following files are available for download:
https://mb.cision.com/Main/15662/3396876/1454428.pdf | Medicover is expanding its fertility network into Norway |
Copyright 2021 PR Newswire
1 Year Medicover Ab Chart |
1 Month Medicover Ab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
